MedPath

Letrozole vs. Clomiphene Citrate in Patients With Anovulatory Infertility

Phase 3
Completed
Conditions
Infertility
Interventions
Registration Number
NCT00610077
Lead Sponsor
Sun Pharmaceutical Industries Limited
Brief Summary

OBJECTIVE: To compare the effectiveness of letrozole and clomiphene citrate (CC) in patients with anovulatory infertility. DESIGN: Open, prospective, randomized, parallel group, multicentric, comparative trial. SETTING: Out patient clinics of infertility centers in India. PATIENT(S): Fifty-five patients with anovulatory infertility were recruited. Twenty-seven patients (59 cycles) were given letrozole and twenty-eight patients (68 cycles) were given CC. Both drugs were given orally on days 3-7 of menstrual cycle. INTERVENTION(S): Letrozole, CC, ovulation induction, vaginal micronized progesterone, IUI.

Detailed Description

MAIN OUTCOME MEASURE(S): Occurrence of ovulation, endometrial thickness and pregnancy rates.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
55
Inclusion Criteria
  • Females with anovulatory infertility 20-38 years of age.
  • Diagnosis of anovulatory infertility as established by standard criteria.
  • Normal Pelvic USG and bilateral tubal patency
  • Willingness and giving written Informed Consent.
Exclusion Criteria
  • Uterine and adnexal pathology e.g. leiomyomata
  • Ovarian cyst
  • Hyperprolactinaemia
  • Hyperthyroidism or Hypothyroidism*
  • FSH >9mIU/ml (during early follicular phase).* (As per Chemoluminescence method)
  • Previous surgery related to genital tract as per history
  • Appendicitis, peritonitis, genital tuberculosis as per history and/or having an abnormal pelvic anatomy
  • Impaired hepatic /renal function
  • Diabetes mellitus/Random blood sugar- > 140mg/dl
  • Drugs likely to interfere with ovulation
  • Alcohol intake as per history
  • History of hypersensitivity to the study drug or to its excipients
  • Planned travel outside the study area for a substantial portion (>5 days) of the study period by potential participants
  • Lack of willingness to give informed written consent
  • Participation in any clinical study within the preceding 1 month

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1LetrozoleLetrozole
2Clomiphene citrateClomiphene citrate
Primary Outcome Measures
NameTimeMethod
Ovulation rate (ovulatory cycles/ all treatment cycles) by Ultrasonography (USG).3 cycles
Secondary Outcome Measures
NameTimeMethod
Pregnancy Rate (Detection of pregnancy by beta-hCG and Ultrasonography) b. Endometrial thickness by Ultrasonography.3 cycles
Safety3 cycles

Trial Locations

Locations (1)

IVF Centre, Chembur,

🇮🇳

Mumbai-, Maharashtra, India

© Copyright 2025. All Rights Reserved by MedPath